PBBI.F Stock Overview
Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Probi AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr19.20 |
| 52 Week High | kr19.20 |
| 52 Week Low | kr16.76 |
| Beta | 0.55 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | 9.71% |
| 3 Year Change | -66.32% |
| 5 Year Change | -47.40% |
| Change since IPO | -48.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| PBBI.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | n/a | 1.5% | 1.2% |
| 1Y | 9.7% | 1.1% | 24.7% |
Return vs Industry: PBBI.F exceeded the US Biotechs industry which returned 1.1% over the past year.
Return vs Market: PBBI.F underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| PBBI.F volatility | |
|---|---|
| PBBI.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.7% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PBBI.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PBBI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 160 | Anita Johansen | www.probi.com |
Probi AB (publ) researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. The company conducts research primarily in the fields of mental, digestive, immune, bone, oral, children’s, women’s, and senior health, as well as iron absorption. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, chilled diary and plant based products, frozen desserts and ice-cream, powder formulas, and recovery drinks.
Probi AB (publ) Fundamentals Summary
| PBBI.F fundamental statistics | |
|---|---|
| Market cap | US$214.57m |
| Earnings (TTM) | -US$55.30k |
| Revenue (TTM) | US$55.81m |
3.8x
P/S Ratio-3,861x
P/E RatioIs PBBI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PBBI.F income statement (TTM) | |
|---|---|
| Revenue | kr607.54m |
| Cost of Revenue | kr410.74m |
| Gross Profit | kr196.80m |
| Other Expenses | kr197.40m |
| Earnings | -kr602.00k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 16, 2024
| Earnings per share (EPS) | -0.053 |
| Gross Margin | 32.39% |
| Net Profit Margin | -0.099% |
| Debt/Equity Ratio | 0% |
How did PBBI.F perform over the long term?
See historical performance and comparison